Clinical Trials in Zurich, Canton of Zurich
2 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled281 locationsNCT06393374
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC1,200 enrolled257 locationsNCT06312176
Recruiting
Breath Analysis for the Detection of Invasive Fungal Infections
LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich130 enrolled1 locationNCT06537726
Recruiting
Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Study
Breast CancerMicrocalcificationImage
University of Zurich350 enrolled2 locationsNCT06489665